Implementation strategies for baby NINJA (nephrotoxic injury negated by just-in-time action) to prevent neonatal medication-induced kidney injury

Authors

Sadie B. Stone, Department of Pharmacy (SBS), Children's of Alabama, Birmingham, AL.
Elizabeth Bisaccia, Advocate Aurora HealthFollow
Mary Soliman Zakhary, Clinical Operations Department (MSZ), Med Communications, Inc, Memphis, TN.
Ferras Bashqoy, Department of Pharmacy (FB), Hassenfeld Children's Hospital at NYU Langone Health, New York, NY.
Deborah Wagner, Department of Pharmacy (DW), Michigan Medicine, Ann Arbor, MI.
Christine Stoops, Department of Pediatrics (CS), University of Alabama at Birmingham, Birmingham, AL.

Recommended Citation

Stone SB, Bisaccia E, Zakhary MS, Bashqoy F, Wagner D, Stoops C. Implementation Strategies for Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action) to Prevent Neonatal Medication-Induced Kidney Injury. J Pediatr Pharmacol Ther. 2023;28(4):287-296. doi:10.5863/1551-6776-28.4.287

Abstract

Acute kidney injury (AKI) is a common complication among patients admitted to the neonatal intensive care unit. Nephrotoxic medications (NTMs) are known to increase the incidence of AKI, but the use of these -medications is often unavoidable. Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action) is a -quality improvement (QI) project that may be implemented at individual institutions and aims to systematically identify AKI in neonates and infants receiving NTMs. The purpose of this review is to describe nephrotoxic AKI in the neonatal population, introduce the Baby NINJA QI project and its potential to reduce neonatal AKI, and outline strategies for effective implementation of Baby NINJA.

Document Type

Article

PubMed ID

37795277